Latest filing published 12 Aug 2026 for Replimune Group, Inc., €128k. Read the official filing
This profile gathers the share dealings of Konstantinos Xynos in Replimune Group, Inc. We count 14 filings; the first trade dates from 1 December 2022 and the latest from 10 August 2026.
The open-market record consists of 8 sales worth €550k, with no purchase. Outside the open market, there are 6 share grants. In 2026 alone, the filings show no purchases and 1 sale.
The record was last updated on 12 August 2026 with an open-market sale (€128k) in Replimune Group, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations